Commission on Cancer honor comes after intensive survey; cancer program expansion set for year end
Reading, Pa. – The cancer program at Penn State Health St. Joseph has been re-accredited by the American College of Surgeon’s Commission on Cancer (CoC).
To again earn the honor, St. Joseph’s cancer program participated in a CoC survey in which it met or exceeded 34 quality care standards, including maintaining high levels of excellence in the delivery of comprehensive, patient-centered cancer care.
According to St. Joseph’s Chief of Oncology, Dr. Marc Rovito, St. Joseph takes a multidisciplinary approach to treating cancer as a complex group of diseases that requires consultation among surgeons, medical and radiation oncologists, diagnostic radiologists, pathologists, and other cancer specialists. This collaborative method results in improved patient care.
St. Joseph’s Director of Oncology Services, Karen Wagner, notes that CoC provides the framework for St. Joseph to continue to improve the quality of its cancer care through a focus on prevention, early diagnosis, cancer staging, optimal treatment, rehabilitation, life-long follow-up for recurrent disease and end-of-life care.
In addition, she elaborates, when patients receive care at St. Joseph they have access to information on clinical trials and new treatments, genetic counseling, and patient-centered services including psycho-social support, a patient navigation process, and a survivorship care plan that documents care and seeks to improve quality of life.
Like all CoC-accredited facilities, St. Joseph maintains a cancer registry and contributes to the National Cancer Data Base (NCDB), a joint program of the CoC and American Cancer Society. This nationwide oncology outcomes collective is the largest clinical disease registry in the world. Data on all types of cancer are tracked and analyzed through the NCDB and used to explore trends in cancer care.